Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook

(NYSE: ECVT) Ecovyst Inc. reported third quarter 2026 results, reflecting the inclusion of the Calabrian sulfur dioxide and related derivatives business acquired on June 30, 2026, and the exclusion of the divested Advanced Materials & Catalysts business, which is now reported in discontinued operations. Third quarter 2026 sales from continuing operations grew 51% to $308.6 million, an increase of $103.7 million from $204.9 million in the third quarter of 2025. Net income for the quarter was $18.4 million, up from $0.2 million in the prior year, with a net income margin of 6.0% and diluted net income per share of $0.17. Adjusted Net Income was $25.3 million, compared to $21.5 million in the year-ago quarter, and Adjusted Diluted Income per share was $0.23. Adjusted EBITDA was $61.2 million, an increase of $3.7 million or 6% compared to $57.5 million in the third quarter of 2025. Cash flow from operating activities for the nine months ended September 30, 2026 was $80.7 million, compared to $77.0 million for the same period in 2025. Adjusted Free Cash Flow for the nine months ended September 30, 2026 was $32.4 million, compared to $42.4 million in the prior year period. As of September 30, 2026, cash and cash equivalents were $71.2 million, total gross debt was $497.1 million, and availability under the Asset-Based Lending facility was $95.8 million, after $2.2 million of outstanding letters of credit, resulting in total available liquidity of $167.0 million. The Net Debt to Net Income Ratio was 9.7x and the Net Debt Leverage Ratio was 2.1x, up from 1.2x at December 31, 2025, due to a $100 million increase in the term loan for the Calabrian acquisition. The company repurchased $2.7 million of its common stock in the third quarter of 2026 and intends to repurchase up to a total of $20 million in the second half of 2026. As of September 30, 2026, $143.8 million remained available for stock repurchases under the program. During the third quarter of 2026, 263,719 shares were repurchased at an average price of $10.25 per share. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $208 million to $212 million, sales guidance to $1,050 million to $1,070 million, Adjusted Free Cash Flow guidance to $50 million to $60 million, capital expenditures to $90 million to $95 million, interest expense to $19 million to $21 million, depreciation & amortization to $84 million to $88 million, and Adjusted Net Income to $70 million to $85 million with Adjusted Diluted Income per share of $0.63 to $0.77. The sales outlook assumes higher average sulfur prices and a higher projected pass-through of sulfur costs of approximately $220 million. The company expects demand for regenerated and virgin sulfuric acid to remain positive for the remainder of 2026, with high refinery utilization and strong alkylate demand supporting regenerated sulfuric acid sales, and ongoing growth in copper mining applications benefiting virgin sulfuric acid sales. For the Calabrian business, high operating rates for Canadian gold mines are expected to continue in the fourth quarter. The company remains flexible in capital allocation, pursuing both organic and inorganic growth opportunities and returning capital to stockholders through share repurchases.

Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook

(NYSE: ECVT) Ecovyst Inc. reported second quarter 2026 sales of $250.0 million, representing a 42% increase of $73.9 million from $176.1 million in the second quarter of 2025. Net income for the quarter was $10.7 million, up from $5.0 million in the prior year, with a net income margin of 4.3% and diluted net income per share of $0.10. Adjusted EBITDA grew 27% to $53.1 million, an increase of $11.2 million from $41.9 million in the second quarter of 2025. Cash flow from operating activities for the six months ended June 30, 2026 was $55.2 million, compared to $25.3 million for the same period in 2025, and adjusted free cash flow was $12.8 million versus $(2.4) million. On June 30, 2026, Ecovyst completed the strategic acquisition of the Calabrian sulfur dioxide and related derivatives business from INEOS Enterprises, which is expected to contribute $10 million to $12 million in Adjusted EBITDA in the second half of 2026. The company raised its full-year 2026 guidance to sales of $1,020 million to $1,060 million and Adjusted EBITDA of $195 million to $207 million. As of June 30, 2026, $146.5 million was available for stock repurchases under the program, and for the six months ended June 30, 2026, the company repurchased 3,226,461 shares at an average price of $11.07 per share for a total cost of $35.7 million.

Ecovyst Completes Acquisition of Calabrian, Expanding Position as a Leading Provider of Sulfur-Based Chemistries and Technologies

(NYSE: ECVT) Ecovyst Inc. announced that it has completed its acquisition of the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises. The Calabrian acquisition expands Ecovyst's capabilities into sulfur dioxide and related derivatives, further diversifying the company's portfolio and end use exposures. Calabrian strengthens Ecovyst's presence in core applications such as mining and water treatment while providing entry into attractive adjacent industry applications, including food processing and pharmaceuticals. Ecovyst is a leading provider of sulfuric acid regeneration, virgin sulfuric acid and sulfur dioxide and related derivatives essential to customer operations and processes. Ecovyst is a leading provider of sulfuric acid recycling to the North American refining industry for the production of alkylate, an essential gasoline component. Ecovyst is a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. Through its Calabrian business, Ecovyst is also a leading producer of sulfur dioxide and related derivatives in North America, serving key end uses including mining, water treatment and specialty chemical production.

Ecovyst Issues 2025 Corporate Sustainability Report

(NYSE: ECVT) Ecovyst Inc. announced the release of its 2025 Sustainability Report, titled "Clean Fuels & Critical Materials Powered by Reliable Sulfur Solutions." The report features 2025 data, including health, safety, environment, and security (HSES), greenhouse gas emissions, energy, water, and waste results. Ecovyst is a leading provider of virgin sulfuric acid, sulfuric acid regeneration services, and sulfuric acid derivatives. The company is a leading provider of sulfuric acid recycling to the North American refining industry for the production of alkylate, an essential gasoline component. Ecovyst is also a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. The company provides chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry. Ecovyst is committed to delivering sulfur products and services to critical industries that produce clean fuels, enable conductivity for data technologies, and support re-industrialization in North America.

Ecovyst Completes Term Loan Amendment and Increase

Ecovyst Inc. (NYSE: ECVT) announced the completion of the syndication of a $100 million fungible Term Loan B add-on, which it intends to use to finance part of its pending acquisition of the Calabrian sulfur dioxide and sulfur derivatives business from INEOS Enterprises. The acquisition and the loan add-on are anticipated to close by the end of the second quarter of 2026. The add-on was issued at par and is co-terminus with the company's existing $397 million Term Loan B, due June 2031, at a floating rate of SOFR plus 2.00 percent per annum. Ecovyst is a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services. This transaction is significant for investors as it involves a major acquisition and substantial financing activity.

Ecovyst Announces Term Loan Amendment and Increase

Ecovyst Inc. (NYSE: ECVT) announced its intention to issue a $100 million fungible Term Loan B add-on to finance its pending acquisition of the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises. The acquisition is targeted to close by the end of the second quarter 2026, with the loan add-on expected to be co-terminus with the existing $397 million Term Loan B due June 2031. The company expects its combined net debt leverage ratio would be approximately 2x at close of the transaction. This financing structure is intended to optimize the acquisition process and financial position.

Ecovyst Reports First Quarter 2026 Results and Revises 2026 Outlook

Ecovyst Inc. (NYSE: ECVT) reported strong first quarter 2026 results, with sales of $215.0 million, up 50% from $143.1 million in Q1 2025. Net income was $5.7 million, reversing a net loss of $8.1 million in the prior year quarter, and adjusted EBITDA rose 87% to $39.8 million. The company completed the sale of its Advanced Materials & Catalysts business on December 31, 2025, and repurchased $35.7 million of common stock in Q1 2026. Ecovyst revised its full-year 2026 guidance, projecting sales of $890 million to $970 million and adjusted EBITDA of $180 million to $195 million.

Ecovyst Announces Agreement to Acquire Calabrian Sulfur Dioxide & Sulfur Derivatives Business

Ecovyst Inc. (NYSE: ECVT) announced it has signed a definitive agreement to acquire the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises for a purchase price of $190 million, subject to certain customary adjustments. Calabrian operates manufacturing facilities in Port Neches, Texas and Timmins, Ontario, Canada, and is a leading producer of sulfur dioxide and related derivatives in North America. The transaction is targeted to close by the end of the second quarter of 2026, pending customary closing conditions. Ecovyst intends to fund the acquisition through a combination of cash on hand and new debt financing. Calabrian's trailing twelve-month Adjusted EBITDA is approximately $23.7 million, and the purchase multiple is approximately 8.0x trailing twelve-month Adjusted EBITDA.